Literature DB >> 25451049

Susceptibility profiles of amphotericin B and posaconazole against clinically relevant mucorales species under hypoxic conditions.

Elisabeth Maurer1, Ulrike Binder2, Manuela Sparber1, Michaela Lackner1, Rita Caramalho1, Cornelia Lass-Flörl1.   

Abstract

The effect of hypoxic conditions on the in vitro efficacy of amphotericin B and posaconazole against Mucorales was evaluated by defining MICs with Etest and broth microdilution and identifying minimal fungicidal concentrations (MFCs). With Etest, oxygen-dependent changes were detected, while the MIC and the MFC determined with broth microdilution remained unaltered with reduced oxygen levels. The observed differences depended on the method used.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25451049      PMCID： PMC4335829          DOI： 10.1128/AAC.04424-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

1.  Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and Candida.

Authors:  Peter A Warn; A Sharp; J Guinea; David W Denning
Journal:  J Antimicrob Chemother       Date:  2004-03-24       Impact factor: 5.790

Review 2.  Hyperbaric oxygen as an adjunctive treatment for zygomycosis.

Authors:  B V John; G Chamilos; D P Kontoyiannis
Journal:  Clin Microbiol Infect       Date:  2005-07       Impact factor: 8.067

3.  Susceptibility testing of Aspergillus flavus: inoculum dependence with itraconazole and lack of correlation between susceptibility to amphotericin B in vitro and outcome in vivo.

Authors:  J Mosquera; P A Warn; J Morrissey; C B Moore; C Gil-Lamaignere; D W Denning
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

Review 4.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Authors:  Maureen M Roden; Theoklis E Zaoutis; Wendy L Buchanan; Tena A Knudsen; Tatyana A Sarkisova; Robert L Schaufele; Michael Sein; Tin Sein; Christine C Chiou; Jaclyn H Chu; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2005-07-29       Impact factor: 9.079

5.  Hyperbaric oxygen as an adjunct in zygomycosis: randomized controlled trial in a murine model.

Authors:  D M Barratt; K Van Meter; P Asmar; T Nolan; C Trahan; L Garcia-Covarrubias; S E Metzinger
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

6.  Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions.

Authors:  Susanne Perkhofer; Daniel Jost; Manfred P Dierich; Cornelia Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

7.  Analysis of pH, pO2 and pCO2 in drainage fluid allows for rapid detection of infectious complications during the follow-up period after abdominal surgery.

Authors:  H P Simmen; H Battaglia; P Giovanoli; J Blaser
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553

8.  Hyperbaric oxygen in the treatment of invasive fungal infections: a single-center experience.

Authors:  Eran Segal; Monty J Menhusen; Simmons Shawn
Journal:  Isr Med Assoc J       Date:  2007-05       Impact factor: 0.892

9.  Amphotericin B-induced oxidative damage and killing of Candida albicans.

Authors:  M L Sokol-Anderson; J Brajtburg; G Medoff
Journal:  J Infect Dis       Date:  1986-07       Impact factor: 5.226

10.  Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus.

Authors:  C Bartizal; F C Odds
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191
View more
  9 in total

1.  Etest cannot be recommended for in vitro susceptibility testing of mucorales.

Authors:  Rita Caramalho; Elisabeth Maurer; Ulrike Binder; Ricardo Araújo; Somayeh Dolatabadi; Cornelia Lass-Flörl; Michaela Lackner
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

2.  Evaluation of the Gradient Concentration Strip Method for Antifungal Susceptibility Testing of Isavuconazole and Comparators for Mucorales Species.

Authors:  Pauline Vidal; Patrick Schwarz; Eric Dannaoui
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

3.  Stable and reproducible homologous recombination enables CRISPR-based engineering in the fungus Rhizopus microsporus.

Authors:  Carlos Lax; María Isabel Navarro-Mendoza; Carlos Pérez-Arques; Eusebio Navarro; Francisco Esteban Nicolás; Victoriano Garre
Journal:  Cell Rep Methods       Date:  2021-12-06

Review 4.  Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis.

Authors:  Laura C García-Carnero; Héctor M Mora-Montes
Journal:  J Fungi (Basel)       Date:  2022-04-25

5.  Sterol Composition of Clinically Relevant Mucorales and Changes Resulting from Posaconazole Treatment.

Authors:  Christoph Müller; Thomas Neugebauer; Patrizia Zill; Cornelia Lass-Flörl; Franz Bracher; Ulrike Binder
Journal:  Molecules       Date:  2018-05-19       Impact factor: 4.411

Review 6.  Role of the Non-Canonical RNAi Pathway in the Antifungal Resistance and Virulence of Mucorales.

Authors:  José Tomás Cánovas-Márquez; María Isabel Navarro-Mendoza; Carlos Pérez-Arques; Carlos Lax; Ghizlane Tahiri; José Antonio Pérez-Ruiz; Damaris Lorenzo-Gutiérrez; Silvia Calo; Sergio López-García; Eusebio Navarro; Francisco Esteban Nicolás; Victoriano Garre; Laura Murcia
Journal:  Genes (Basel)       Date:  2021-04-17       Impact factor: 4.096

7.  In Vitro Antifungal Drug Resistance Profiles of Clinically Relevant Members of the Mucorales (Mucoromycota) Especially with the Newer Triazoles.

Authors:  Andrew M Borman; Mark Fraser; Zoe Patterson; Michael D Palmer; Elizabeth M Johnson
Journal:  J Fungi (Basel)       Date:  2021-04-02

Review 8.  Genetic Manipulation in Mucorales and New Developments to Study Mucormycosis.

Authors:  Carlos Lax; José Tomás Cánovas-Márquez; Ghizlane Tahiri; Eusebio Navarro; Victoriano Garre; Francisco Esteban Nicolás
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

Review 9.  Genes, Pathways, and Mechanisms Involved in the Virulence of Mucorales.

Authors:  Carlos Lax; Carlos Pérez-Arques; María Isabel Navarro-Mendoza; José Tomás Cánovas-Márquez; Ghizlane Tahiri; José Antonio Pérez-Ruiz; Macario Osorio-Concepción; Laura Murcia-Flores; Eusebio Navarro; Victoriano Garre; Francisco Esteban Nicolás
Journal:  Genes (Basel)       Date:  2020-03-16       Impact factor: 4.096
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.